Evidence map›Paper›PMID 29712626›Full record

ArticleJMIR public health and surveillance2018

A Gamified Smartphone App to Support Engagement in Care and Medication Adherence for HIV-Positive Young Men Who Have Sex With Men (AllyQuest): Development and Pilot Study.

Lisa Hightow-Weidman, Kathryn Muessig, Kelly Knudtson, Mala Srivatsa, Ellena Lawrence, Sara LeGrand, Anna Hotten, Sybil Hosek

Abstract read
In one paragraph

Article in JMIR public health and surveillance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lisa Hightow-WeidmanInstitute of Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, United States.ORCID http://orcid.org/0000-0002-2421-923X
Kathryn MuessigDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States.ORCID http://orcid.org/0000-0002-8522-3240
Kelly KnudtsonInstitute of Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, United States.ORCID http://orcid.org/0000-0002-5293-1961
Mala SrivatsaAyogo, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-8986-6120
Ellena LawrenceAyogo, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-5409-3658
Sara LeGrandDuke Global Health Institute, Duke University, Durham, NC, United States.ORCID http://orcid.org/0000-0002-2590-516X
Anna HottenDepartment of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, United States.ORCID http://orcid.org/0000-0002-4570-8155
Sybil HosekDepartment of Psychiatry, Stroger Hospital of Cook County, Chicago, IL, United States.ORCID http://orcid.org/0000-0001-5230-0759

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHIV disproportionately impacts young men who have sex with men (YMSM) who experience disparities across the HIV care continuum. Addressing antiretroviral therapy (ART) adherence among YMSM is an urgent public health priority. Technology-based interventions-particularly mobile health platforms-can provide tailored adherence interventions and allow YMSM to engage and connect with others.

objectiveThe objective of this study was to describe the development of AllyQuest, a novel, theoretically-based, smartphone app designed to improve engagement in care and ART adherence and social support among HIV-positive YMSM.

methodsAllyQuest was built on an established platform for patient engagement that embeds social networking and fundamental game mechanics, such as challenges, points, and rewards. A medication tracker provides reminders to promote ART adherence via personalized adherence strategies that are user and context specific; a calendar allows for reflection on adherence over time. After iterative development with input from two youth advisory boards, usability testing was conducted to assess app functionality, comprehension of the educational content, use of intervention features, and overall impressions of app relevance and appeal. A 28-day pilot trial was conducted with 20 HIV+ YMSM to evaluate intervention feasibility and acceptability.

resultsMean age of participants was 21.8 years (range 19-24), and 95% (19/20) of the participants were nonwhite. The mean time of app use was 158.4 min (SD 114.1), with a range of 13 to 441 min. There was a mean of 21.2 days of use (out of a total possible 28 days). There were 222 posts to the daily discussion social wall. Feasibility and acceptability ratings were high. Overall, participants found the app easy to use and navigate, not intrusive, and had few reported technical issues. Higher levels of app usage were positively correlated with HIV self-management outcomes, and there was a statistically significant (P<.05) positive association between the number of days logged into the app and knowledge and confidence in ability to reliably take HIV medications.

conclusionsAllyQuest represents a new, highly scalable solution that is well-suited to meet the specific prevention and care needs of HIV+ YMSM. The development of this intervention is both timely and vital, given the urgency of the ongoing HIV epidemic among YMSM.

Indexed as

antiretroviral adherencegamificationsmartphone appsocial networkingYMSM

Identifiers

PMID29712626
PMCPMC5952121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.